Bridging the divide between the promises of AI and the current realities of biomanufacturing is critical to achieve the next generation of biopharma production. See what James Colley, Ph.D., a senior director of BioPhorum, has to say about it: bioprocessonline.com/doc/on-…

Will Olughu, Ph.D., came on the "Better Biopharma" podcast to discuss process modeling and AI applications in biopharma manufacturing. He explains what digital twins are (and aren't) and the challenge of implementation in GMP environments. Listen here: bioprocessonline.com/doc/imp…

Tonix Pharmaceuticals' chief technical officer appeared on the "Better Biopharma" podcast to talk about the planning and construction of its purpose-built vaccine manufacturing facility. Check out the full interview wherever you get your podcasts! bioprocessonline.com/doc/bui…

"AI systems built on broken architecture just fail faster and more expensively," said Martin Kockx, a principal manufacturing systems engineer at Vertex. Bioprocess Online caught up with him after his presentation at BPI. See the full interview here: bioprocessonline.com/doc/con…

On #BusinessOfBiotech #podcast, @AkariTX's @RachelleJ7k discusses the redeeming qualities of #tick saliva and how her company is putting it to work to treat rare but deadly severe hematopoietic stem cell transplant-related thrombotic microangiopathy. bioprocessonline.com/doc/tic…

On #BusinessOfBiotech #podcast, @AkariTX's @RachelleJ7k discusses the redeeming qualities of #tick saliva and how her company is putting it to work to treat rare but deadly severe hematopoietic stem cell transplant-related thrombotic microangiopathy. bioprocessonline.com/doc/tic…

@ElicioTx’s novel Amphiphile Technology Platform directly engages the lymphatic system in the deployment and delivery of therapeutic payloads. #BusinessOfBiotech caught up with CSO Peter DeMuth to learn how the platform works. In partnership with @Cytiva. bioprocessonline.com/doc/lev…

On #BusinessOfBiotech #podcast, @AkariTX's @RachelleJ7k discusses the redeeming qualities of #tick saliva and how her company is putting it to work to treat rare but deadly severe hematopoietic stem cell transplant-related thrombotic microangiopathy. bioprocessonline.com/doc/tic…

@ElicioTx’s novel Amphiphile Technology Platform directly engages the lymphatic system in the deployment and delivery of therapeutic payloads. #BusinessOfBiotech caught up with CSO Peter DeMuth to learn how the platform works. In partnership with @Cytiva. bioprocessonline.com/doc/lev…

Check out #BioprocessOnlineLive for a discussion on the application of process analytical technologies in biopharma manufacturing featuring Paul Testa, @KyowaKirin_US, @PharmatechA, and our own Matthew Pillar. Supported by @SartoriusGlobal. bioprocessonline.com/doc/bio…

@ElicioTx’s novel Amphiphile Technology Platform directly engages the lymphatic system in the deployment and delivery of therapeutic payloads. #BusinessOfBiotech caught up with CSO Peter DeMuth to learn how the platform works. In partnership with @Cytiva. bioprocessonline.com/doc/lev…

#BusinessOfBiotech #podcast is brought to you by @BioProcessOL in partnership with @Cytiva. Check out this week’s episode featuring @abbvie VP of Oncology Discovery, Steve Davidsen. #oncology #drugdiscovery #computationalbiology bioprocessonline.com/doc/onc…

Available On-Demand - a discussion on the scientific-, development-, and business-related advancements that will enable the RNA therapeutics industry to meet the needs of a broader array of patient populations. Supported by Precision NanoSystems. bioprocessonline.com/doc/lnp…

Check out #BioprocessOnlineLive for a discussion on the application of process analytical technologies in biopharma manufacturing featuring Paul Testa, @KyowaKirin_US, @PharmatechA, and our own Matthew Pillar. Supported by @SartoriusGlobal. bioprocessonline.com/doc/bio…

@Obsidian_Tx's Paul Wotton takes #BusinessOfBiotech #podcast listeners behind the scenes to reveal what precipitated the FDA's clearance of its IND application for a novel, engineered tumor-infiltrating lymphocyte therapy called #OBX115. bioprocessonline.com/doc/ind…

Here's the story of BioStem Technologies (OTC: BSEM), its young founders, and how they reached commercial status in short order with a portfolio of proprietary regenerative wound care products developed from perinatal tissue. bioprocessonline.com/doc/reg…

#BusinessOfBiotech #podcast is brought to you by @BioProcessOL in partnership with @Cytiva. Check out this week’s episode featuring @abbvie VP of Oncology Discovery, Steve Davidsen. #oncology #drugdiscovery #computationalbiology bioprocessonline.com/doc/onc…

Available On-Demand - a discussion on the scientific-, development-, and business-related advancements that will enable the RNA therapeutics industry to meet the needs of a broader array of patient populations. Supported by Precision NanoSystems. bioprocessonline.com/doc/lnp…

While the “rollout” of harmonized global regulatory requirements might be happening at a snail’s pace, progress is being made and the ICH remains the driver. #BioprocessOnlineLive bioprocessonline.com/doc/whe…

Check out #BioprocessOnlineLive for a discussion on the application of process analytical technologies in biopharma manufacturing featuring Paul Testa, @KyowaKirin_US, @PharmatechA, and our own Matthew Pillar. Supported by @SartoriusGlobal. bioprocessonline.com/doc/bio…